Sign in
4

Changes in Ownership

ACADIA PHARMACEUTICALS INC Filed Acc 0001415889-17-000407

Options or other derivatives

  • EVP, CHIEF COMMERCIAL OFFICER acquired 33,750 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Moore Terrence O EVP, CHIEF COMMERCIAL OFFICER 2017-03-08 Grant or award · Stock Option (right to buy) +33,750 33,750 D
Loading xslF345X03/form4-03102017_050310.xml…